CMPI Event: “Personalized Medicine and Responsible Access to Pain Medication.”

  • by: |
  • 08/07/2013
Please join the Center for Medicine in the Public Interest (www.cmpi.org) and some of the nation’s top experts for an interactive panel discussion of “Personalized Medicine and Responsible Access to Pain Medication.”

A Capitol Hill Briefing

When: September 10, 2013 from 9:30AM – 2:15PM

Where: Rayburn House Office Building B338, Washington DC

RSVP: Mario Coluccio at mcoluccio@cmpi.org

BREAKFAST & LUNCH TO BE SERVED

AGENDA

9:30- 10AM:  Breakfast and Registration

10AM: Welcome
            Peter Pitts & Robert Goldberg, Center for Medicine in the Public Interest

10:15: Keynote: FDA Regulation and Responsible Access to Pain Medication
            Douglas Throckmorton, Deputy Director, Regulatory Programs, CDER, FDA

11:00: Access to Pain Medications: The Role of Patients and Manufacturers
            Moderator: Steve Usdin, BioCentury
            Cindy Steinberg, US Pain Foundation
            Bob Twillman, American Academy of Pain Management
            Stuart Kim, Mallinckrodt Pharmaceuticals

11:45: Break and Lunch

12:00: Issue:  Pain Medications:  Two Reporters Views
            Moderator: Peter Pitts, CMPI
            Barry Meier, New York Times
            Judy Foreman, Syndicated Columnist

1:30:  Closing Keynote: Pain Medications and the Future of Personalized Medicine
            Introduction: Bob Goldberg, CMPI
            Charles Inturrisi, Weill Cornell Medical Center
 
2:15: Closing Remarks
 
Peter Pitts & Robert Goldberg, Center for Medicine in the Public Interest
 
RSVP: Mario Coluccio at mcoluccio@cmpi.org

BREAKFAST & LUNCH TO BE SERVED
 

CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog